Tooru Nemoto, PhD
Health Intervention Projects for Underserved Populations
Tooru Nemoto, PhD, is research program director and founder of the Health Intervention Project for Underserved Populations (HIPUP) at PHI and oversees a number of substance abuse and HIV prevention studies and programs for stigmatized and neglected populations, such as Asian and Pacific Islander men who have sex with men, transgender and gender non-binary people, substance users, and sex workers.
Nemoto's research focuses on the social and cultural contexts of substance use and HIV-related risk behaviors, as well as racial/ethnic, gender, and sexual identity. He collaborates with substance abuse and HIV/AIDS care and prevention agencies in the San Francisco Bay Area and researchers in Asian countries, such as Japan, Thailand, and Malaysia.
Before joining PHI in 2007, Nemoto was associate professor in the Department of Medicine at the University of California, San Francisco (UCSF). He has been a review member for the National Institutes of Health's (NIH) study sections and was co-chair for the National Institute on Drug Abuse Asian American and Pacific Islander Workgroup from its inception in 1999 until 2006.
Nemoto is funded by federal and state agencies (e.g., NIH, the Substance Abuse and Mental Health Services Administration, the Health Resources and Services Administration, the California HIV/AIDS Research Programs) and private foundations (e.g., Kaiser Foundation) to conduct research and service projects.
Nemoto earned a doctorate in community psychology from New York University and completed postdoctoral work at the Institute for Health Policy Studies at UCSF.
A new pre-print study of over 600,000 veterans by researchers from PHI and the Veterans Affairs Medical Center finds that overall COVID-19 vaccine protection declined significantly between February and August 2021. Declines were greatest for the Johnson & Johnson vaccine (from 88% in March to 3% in August), followed by PfizerBioNTech (91% to 50%) and Moderna (92% to 64%).